Berekum

Researchers are studying the ADHINCRA Program, which aims to improve the control of high blood pressure in Africa by addressing factors related to patients, healthcare providers, and health systems. This program hopes to reduce the risk of serious health problems like heart disease, stroke, and kidney disease by helping people manage their hypertension better. The study focuses on adults aged 18 to 70 years who have high blood pressure but do not have diabetes. The ADHINCRA Program is a nurse-led approach that includes home blood pressure monitoring, a mobile health app for support, lifestyle counseling, and a simplified treatment plan for hypertension. Participants either have not been treated for hypertension before or are on a single medication. The program is delivered through primary care centers at participating sites. Participants will be monitored for changes in their blood pressure over 12 months, with the main measure being the number of people whose systolic blood pressure falls below 140 mmHg. The study includes regular assessments and uses technology to support treatment adherence. The total participation period involves baseline measurements and follow-up at 12 months after starting the program.

This research investigates whether wearable wireless sensors can help detect early signs of patient deterioration after surgery. Patients who become critically unwell after operations often experience delayed recognition of complications, which can lead to harm or death. The study focuses on surgical inpatients undergoing major open surgery across various countries and aims to see if data from wearable monitors is acceptable to patients and healthcare staff while potentially improving early detection of problems. Participants will wear wireless sensors placed on their chest and fingers before, during, and after surgery for up to 10 days. These sensors record vital signs like heart rate, oxygen levels, and body temperature continuously but do not affect patient care, as clinical teams will not have access to the sensor data during the study. The study is device-agnostic but initially uses the Sibel ANNEae One device, a wireless dual sensor system that stores real-time physiological data. During the study, researchers will collect and analyze physiological data alongside clinical event information to explore links between vital sign changes and patient deterioration. Participants will be monitored through wearable sensors for up to 10 days postoperatively, with no changes to standard care. The study takes place in general surgery departments in several countries and includes usability assessments and baseline monitoring practice evaluations in earlier stages.